- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2009
- Public Summary Document (PSD) July 2009 PBAC Meeting - PDF
Ambrisentan – July 2009
Ambrisentan, tablets, 5 mg and 10 mg, Volibris®
Last updated
30 October 2009